Embecta now expects revenues between $1.073 billion and $1.09 billion. This would mark a sales dip of between 4.4% and 2.9% ...

(NYSE:SENS) shares dipped after hours today on first-quarter results that beat revenue projections on Wall Street.

Insulet (Nasdaq:PODD) shares got a boost after hours today on first-quarter results that came in ahead of the consensus ...

Dexcom (NASDAQ:DXCM) announced today that it expanded its partnership with Oura, officially launching an integration with ...

Sequel Med Tech and Senseonics today announced a commercial development agreement to combine insulin delivery and glucose ...

Phillips Medisize announced that it officially integrated Vectura into its business, expanding its capabilities in inhaled ...

Medtronic (NYSE:MDT) announced today that it appointed Kate Cronin as the new chief marketing officer for its Diabetes unit.

IDE Group recently unveiled OKO, its new ophthalmic auto-injector for improving drug delivery precision and efficiency.

Abbott announced today that it entered a first-of-its-kind agreement to integrate data from its Libre systems into Epic EHR ...

A mission to outer space includes plans to utilize modern diabetes management technology to assess its viability in ...

Insulet announced today that its board of directors appointed Ashley McEvoy as president and CEO, effective immediately.

Orchestra BioMed (Nasdaq:OBIO) announced that it received FDA investigational device exemption (IDE) for its Virtue ...